-
Mashup Score: 0Funding HAI and Antibiotic Resistance Research - 3 hour(s) ago
AHRQ’s Healthcare-Associated Infections (HAI) Division funds clinical and health services research to develop the knowledge and practical tools used on the frontlines to prevent infections and make care safer. AHRQ is interested in funding research in all clinical settings—acute care, long-term care, and ambulatory care—in accordance with the framework established by the Department of Health and Human Services’ National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination and the research agenda of the Combating Antibiotic Resistant Bacteria Action Plan.
Source: www.ahrq.govCategories: General Medicine News, PayerTweet
-
Mashup Score: 0Investigating Interventions to Reduce Unsafe Use of Antibiotics - 3 hour(s) ago
Larissa Grigoryan, M.D., Ph.D.Associate Professor of Family and Community MedicineBaylor College of Medicine
Source: www.ahrq.govCategories: General Medicine News, PayerTweet-
A new #AHRQ Grantee Profile highlights work from Larissa Grigoryan, MD, PhD, to prevent inappropriate antibiotic use, which can drive resistance. Learn more this #USAAW24! https://t.co/QdGCUX5HNW https://t.co/HqaCUDDZeD
-
-
Mashup Score: 1AHRQ's Healthcare-Associated Infections Program - 3 hour(s) ago
AHRQ’s HAI program funds work to help frontline clinicians and other health care staff prevent HAIs by improving how care is actually delivered to patients. This work is accomplished through a robust portfolio of grants and contracts that focus on applied research—or research that advances the ability of clinicians in the field to combat HAIs. This kind of research brings knowledge to the front lines of care faster by helping clinicians and staff better understand how to apply proven methods of making care safer.
Source: www.ahrq.govCategories: General Medicine News, PayerTweet-
#AHRQ is proud to be part of #IDWeek2023 where clinicians find the latest research and resources for infectious disease. Attendees are invited to stop by booth 1638 to learn about free AHRQ tools and resources. https://t.co/nFYMmgNPCF https://t.co/ijmkHMwFiY
-
-
Mashup Score: 0
Some voters galvanized by Robert F. Kennedy Jr.’s pledge to “Make America Healthy Again” said they believed the health establishment was dismissive and even corrupt.
Source: www.nytimes.comCategories: General Medicine News, PayerTweet-
Trump Wants to Shake Up Health Americans Don’t Mind. https://t.co/n6RxGJSjZ6 OK, many see health agencies as corrupt, arrogant & want to blow it up. But let's start w/ a different, more accurate, premise. CDC, NIH & FDA set the scientific gold standard- the envy of the world.
-
-
Mashup Score: 1Video Conferencing, Web Conferencing, Webinars, Screen Sharing - 4 hour(s) ago
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011, Zoom helps businesses and organizations bring their teams together in a frictionless environment to get more done. Zoom is a publicly traded company headquartered in San Jose, CA.
Source: bsci-nm.zoom.usCategories: General Medicine News, PayerTweet-
Don't miss Thursday's AGENT™ DCB webinar and case-based discussion with Dr. Brian Jefferson. Can't make it? Register now for January's conversation with Dr. Matthew Price! December 5, 7-8 pm ET https://t.co/YMupuLnmvL January 23, 7-8 pm PT https://t.co/ajnFabcNuz https://t.co/xbb1NIViCG
-
-
Mashup Score: 15
First breakthrough therapy designation for investigational sac-TMT in the U.S. Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sacituzumab tirumotecan (sac-TMT) for the treatment of patients with advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations (exon 19 deletion [19del] or exon 21 L858R) whose disease progressed on or after tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy. Sac-TMT is an investigational trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) being developed in collaboration with Kelun-Biotech. This designation is based on data from the Phase 2 expansion cohort of a Phase 1/2 study evaluating sac-TMT in patients with EGFR-mutated NSCLC, which were presented at the 2023 American Society of Clinical Oncology Annual
Source: www.merck.comCategories: General Medicine News, PayerTweet-
The U.S. FDA has granted Breakthrough Therapy designation to our investigational candidate for the treatment of certain patients with advanced or metastatic #NSCLC with EGFR mutations. Learn more here: https://t.co/K8G6QKg5je https://t.co/k7FEx7TA2Y
-
-
Mashup Score: 0Advancing Digital Healthcare Equity: Navigating Disparities in the Digital Age | Digital Healthcare Research - 16 hour(s) ago
Digital technologies hold the potential to enhance outcomes and reduce disparities, however, they can also unintentionally perpetuate or even worsen existing disparities as a result of poor planning, development, deployment, and/or maintenance of such tools and technologies. Join AHRQ’s National Webinar featuring an expert panel of speakers who will highlight recent federal efforts to advance health and digital healthcare equity. The discussion will explore some of the latest frameworks, data, and tools to inform and advance health and digital healthcare equity.
Source: digital.ahrq.govCategories: General Medicine News, PayerTweet-
Don't miss #AHRQ's National Webinar on December 3, 3-4:30 pm ET, exploring how digital tools can enhance outcomes & reduce disparities - or worsen them if poorly implemented. Register now! #DigitalHealth https://t.co/zCNVSjVFpP https://t.co/8FiOAIvI68
-
-
Mashup Score: 0What’s Next for Health Care Policy in the US? - 17 hour(s) ago
With new faces and shifting power dynamics in Washington, concerns about health care policy in 2025 are rising, including potential reform of PBMs, the 340B program, and the IRA, as well as the push for expanded access to innovative therapies like prescription digital therapeutics.
Source: www.hmpgloballearningnetwork.comCategories: General Medicine News, PayerTweet-
Check out AVP @AdamColborn's article in @FirstReportMC highlighting 5 key issues health care professionals should prepare for during the incoming presidential administration. The path forward is a little uncertain—but full of potential for progress. https://t.co/eNcbNyVuZf https://t.co/4akhhpOGim
-
-
Mashup Score: 1AHRQ's Healthcare-Associated Infections Program - 17 hour(s) ago
AHRQ’s HAI program funds work to help frontline clinicians and other health care staff prevent HAIs by improving how care is actually delivered to patients. This work is accomplished through a robust portfolio of grants and contracts that focus on applied research—or research that advances the ability of clinicians in the field to combat HAIs. This kind of research brings knowledge to the front lines of care faster by helping clinicians and staff better understand how to apply proven methods of making care safer.
Source: www.ahrq.govCategories: General Medicine News, PayerTweet-
#AHRQ is proud to be part of #IDWeek2023 where clinicians find the latest research and resources for infectious disease. Attendees are invited to stop by booth 1638 to learn about free AHRQ tools and resources. https://t.co/nFYMmgNPCF https://t.co/ijmkHMwFiY
-
-
Mashup Score: 0Webinar: Person-Centered Care Planning for People With Multiple Chronic Conditions | Agency for Healthcare Research and Quality - 18 hour(s) ago
WhenDecember 3, 2024 at 1:00 p.m. ET
Source: www.ahrq.govCategories: General Medicine News, PayerTweet-
Join us Dec. 3, 1–2 p.m. ET, for a webinar that will present preliminary findings from an #AHRQ-funded project exploring approaches to delivering person-centered care for individuals managing multiple chronic conditions. Register today. #PatientCare https://t.co/ami321syGU https://t.co/BCna2jcja3
-
#AHRQ is supporting #research to prevent healthcare-associated infections and combat antibiotic-resistant bacteria. Submit your innovative proposals before September 25. Review important policy updates: https://t.co/tJoNZaZ2cp https://t.co/WksRofDQ2c